Genentech discovers possible prenatal clue to Alzheimer's disease

02/18/2009 | Wall Street Journal, The

Researchers at Genentech proposed that N-APP, a fragment of the amyloid precursor protein, causes the death of nerve cells and fibers in Alzheimer's patients by triggering a process that destroys the cells. This normally happens during prenatal development to get rid of excess cells, but Genentech scientists found that the process can somehow reactivate during adulthood.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Santa Clara, CA
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA